COMMUNIQUÉS West-GlobeNewswire

Vireo Growth Inc. Announces Acquisition of The Hawthorne Gardening Company from The Scotts Miracle-Gro Company
09/04/2026
Transaction further strengthens the Company’s balance sheet with approximately US$110 million of combined cash and net working capital Consideration of 213 million shares at a deemed price of US$0.60 and 80 million [...]
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction
08/04/2026
LANGHORNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high- [...]
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
08/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
08/04/2026
AX-0810 clinical target engagement data in healthy volunteers on track for this quarter; biliary atresia selected as initial Phase 2 indication Additional programs advancing toward the clinic, including AX-0811 and AX- [...]
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
08/04/2026
WILMINGTON, Del., April 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the [...]
Telix Strengthens Board with Additional Director Appointments
09/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, [...]
Option Care Health to Announce First Quarter 2026 Financial Results and Host Conference Call
08/04/2026
BANNOCKBURN, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
08/04/2026
ZUG, Switzerland, April 08, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to a director of the Company. Attachment Notification of managers' [...]
Universal Door Meditation Center Hosts Free Public Celebration of Awakened Zen Master Thich Dieu Thien's 25-Year Milestone April 11 in Sugar Land, Texas
08/04/2026
What does it mean to meet one of the world's few fully Awakened teachers? A free community event on April 11 invites everyone to meet and be awakened by two of the world's rarest living spiritual teachers and no [...]
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness
08/04/2026
Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- AVITA [...]
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/04/2026
SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
08/04/2026
Digital solution will be designed to help guide users through injection process CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient [...]
Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F
08/04/2026
Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies [...]
Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check
08/04/2026
A 2026 overview of Found Health's GLP-1 medication access model, free online insurance coverage check, disclosed pricing for Wegovy, Zepbound, Ozempic, and compounded semaglutide options, telehealth program structure, [...]
Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance
08/04/2026
A 2026 informational consumer report on the Neura Supplement red goji berry recipe memory trick, cognitive shield claims, Lion's Mane and Bacopa ingredient research context, dementogen positioning, and what adults over [...]
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
08/04/2026
- Ordinary shares expected to commence trading on Nasdaq on April 20, 2026 following exchange of all American Depositary Shares (ADSs) - ADS holders will receive one ordinary share listed on Nasdaq for each ADS held - [...]
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
08/04/2026
Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health , a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment for international [...]
Sanofi - Assemblée Générale Mixte du 29 avril 2026 - Mise à disposition des documents préparatoires
08/04/2026
ASSEMBLÉE GÉNÉRALE MIXTE DU 29 AVRIL 2026 MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de la Société sont invités à participer à l’assemblée générale mixte qui se [...]
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
08/04/2026
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain cancer model that [...]

Pages